Succeeding in New Vaccine Introduction: Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Cameroon, Kenya, and Nigeria

J Infect Dis. 2017 Jul 1;216(suppl_1):S130-S136. doi: 10.1093/infdis/jiw544.

Abstract

Introducing a new vaccine is a large-scale endeavor that can face many challenges, resulting in introduction delays and inefficiencies. The development of national task teams and tools, such as prelaunch trackers, for the introduction of new vaccines (hereafter, "new vaccine introductions" [NVIs]) can help countries implement robust project management systems, front-load critical preparatory activities, and ensure continuous communication around vaccine supply and financing. In addition, implementing postlaunch assessments to take rapid corrective action accelerates the uptake of the new vaccines. NVIs can provide an opportunity to strengthen routine immunization, through strengthening program management systems or by reinforcing local immunization managers' abilities, among others. This article highlights key lessons learned during the introduction of inactivated poliovirus vaccine in 3 countries that would make future NVIs more successful. The article concludes by considering how the Immunization Systems Management Group of the Global Polio Eradication Initiative has been useful to the NVI process and how such global structures could be further enhanced.

Keywords: IPV; NVI; Polio; RI; program management; technical working groups.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Africa South of the Sahara
  • Disease Eradication* / methods
  • Disease Eradication* / organization & administration
  • Humans
  • Immunization Programs* / methods
  • Immunization Programs* / organization & administration
  • Poliomyelitis / prevention & control*
  • Poliovirus Vaccine, Inactivated* / administration & dosage
  • Poliovirus Vaccine, Inactivated* / supply & distribution

Substances

  • Poliovirus Vaccine, Inactivated